600812 华北制药
2024/06 - 中期
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资1,223,7521.80%1,202,161900,516858,439581,956
投资性房地产0--0000
固定资产6,642,0133.03%6,446,8316,786,0656,727,2357,885,760
在建工程280,50272.78%162,347154,672672,475617,505
无形资产2,096,7566.17%1,974,8211,650,3321,344,4941,236,794
商誉3,3370.00%3,3373,3373,3373,337
其他非流动资产2,753,564-12.57%3,149,6122,743,1982,611,7591,495,076
12,999,9240.47%12,939,10912,238,11912,217,73911,820,428

流动资产
货币资金1,770,13979.11%988,2761,682,7375,304,9834,907,511
应收账款2,264,22117.26%1,930,9032,231,0661,958,7431,734,216
存货2,605,607-0.08%2,607,7842,523,3012,391,9092,452,923
其他流动资产2,111,473-15.22%2,490,6282,545,7943,056,5613,016,639
8,751,4409.15%8,017,5918,982,89912,712,19612,111,289

流动负债
短期借款5,981,0859.39%5,467,7105,276,0647,626,5256,825,625
应付票据622,5547.14%581,040829,406766,489527,920
应付帐款2,098,2499.92%1,908,8551,953,2272,124,6592,072,551
其他流动负债2,673,28415.68%2,310,9604,350,5223,722,2222,327,230
11,375,17210.78%10,268,56512,409,21914,239,89511,753,326
流动资产净值(2,623,732)16.56%(2,250,974)(3,426,320)(1,527,699)357,963
资产总额减流动负债10,376,192-2.92%10,688,1358,811,79910,690,04012,178,391

非流动负债
长期借款3,623,248-11.21%4,080,8582,129,0703,300,7354,617,835
应付债券0--0000
其他非流动负债198,331-41.12%336,866454,353372,074504,990
3,821,579-13.49%4,417,7252,583,4233,672,8095,122,825

总权益
    实收股本1,715,7300.00%1,715,7301,715,7301,715,7301,630,805
    储备项目3,616,1350.46%3,599,5733,584,3954,369,7514,493,523
股东权益5,331,8660.31%5,315,3045,300,1256,085,4816,124,327
非控股权益1,222,74728.02%955,107928,251931,750931,238